7VG
SKAN Group AG, together with its subsidiaries, provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally. It operates in two segments, Equipment and Solutions; and Services and Consumables. The company offers accessories, biological indicators, digital ventures, isolators, cleanroom, laminar f… Read more
7VG (7VG) - Total Liabilities
Latest total liabilities as of June 2025: €198.06 Million EUR
Based on the latest financial reports, 7VG (7VG) has total liabilities worth €198.06 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
7VG - Total Liabilities Trend (2021–2024)
This chart illustrates how 7VG's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
7VG Competitors by Total Liabilities
The table below lists competitors of 7VG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Guild Holdings Co
NYSE:GHLD
|
USA | $3.86 Billion |
|
Shandong Yisheng Livestock & Poultry Breeding Co Ltd
SHE:002458
|
China | CN¥3.02 Billion |
|
Qingdao Yunlu Advanced Materials Technology Co. Ltd. A
SHG:688190
|
China | CN¥712.28 Million |
|
SonoScape Medical Corp
SHE:300633
|
China | CN¥996.87 Million |
|
Línea Directa Aseguradora S.A
PINK:LNDAF
|
USA | $931.40 Million |
|
Irish Continental Group plc
PINK:IRCUF
|
USA | $393.60 Million |
|
Andlauer Healthcare Gr
TO:AND
|
Canada | CA$248.20 Million |
|
Winpak Ltd
PINK:WIPKF
|
USA | $239.81 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down 7VG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how 7VG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for 7VG (2021–2024)
The table below shows the annual total liabilities of 7VG from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €181.92 Million | -7.69% |
| 2023-12-31 | €197.09 Million | -11.52% |
| 2022-12-31 | €222.76 Million | +41.06% |
| 2021-12-31 | €157.92 Million | -- |